Showing results (281-290 of 302) with videos related to
Sort By:
Pageof 31
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunityA L Marzo, B F Kinnear, R A Lake, et al.Neurochemical Research|January 14, 2011
Effect of hypoxia on expression of selected proteins involved in regulation of apoptotic activity in striatum of newborn pigletsA Mammen, J Kubin, W J Greeley, et al.Immunology|August 1, 1988
Limiting-dilution analysis of T cells extracted from solid human lung tissue: comparison of precursor frequencies for proliferative responses and lymphokine production between lung and blood T cells from individual donorsP G Holt, U R Kees, M A Shon-Hegrad, et al.Neuroscience Letters|July 18, 1997
Adenosine depresses transmitter release but is not the basis for 'tetanic fade' at the neuromuscular junction of the ratM N Malinowski, S B Cannady, K V Schmit, et al.Cancer Research|November 26, 1997
Tamoxifen induces hypoxia in MCF-7 xenograftsS M Evans, C J Koch, K M Laughlin, et al.Neuroscience Letters|October 24, 1994
Effect of hemorrhagic hypotension on extracellular level of dopamine, cortical oxygen pressure and blood flow in brain of newborn pigletsM Yonetani, C C Huang, J McGowan, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 1, 1992
Genetic 'risk' for atopy is associated with delayed postnatal maturation of T-cell competenceP G Holt, J B Clough, B J Holt, et al.The Annals of Otology, Rhinology, and Laryngology|April 1, 1997
Molecular analysis of the POU3F4 gene in patients with clinical and radiographic evidence of X-linked mixed deafness with perilymphatic gusherR A Friedman, Y Bykhovskaya, G Tu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 28, 1998
Intralesional cytokine therapy in cancer: a pilot study of GM-CSF infusion in mesotheliomaJ A Davidson, A W Musk, B R Wood, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II studyM J Byrne, J A Davidson, A W Musk, et al.Pageof 31